Medicus Pharma schedules webcast with Phase 2 trial investigator

March 16, 2026 7:30 AM

Medicus Pharma Ltd. (NASDAQ: MDCX) announced that Dr. Babar K. Rao, the principal investigator of its SkinJect Phase 2 clinical ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found